HCPCS Level II · Transportation, medical and surgical supplies
A9697Injection, carboxydextran-coated superparamagnetic iron oxide, per study dose
✓ Active
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About A9697
A9697 is an HCPCS Level II code in the A series (transportation, medical and surgical supplies), describing injection, carboxydextran-coated superparamagnetic iron oxide, per study dose.
It was added to HCPCS effective 10/01/2023, and its current record took effect 01/01/2025.
Its Medicare coverage code is "C", meaning coverage is left to the Medicare contractor's judgment.
Details
- Short description
- Inj, magtrace per study dose
- Date added
- 10/01/2023
- Action effective
- 01/01/2025
- BETOS
- I1E
Related A96xx codes
- A9600Strontium sr-89 chloride, therapeutic, per millicurie
- A9601Flortaucipir f 18 injection, diagnostic, 1 millicurie
- A9602Fluorodopa f-18, diagnostic, per millicurie
- A9603Injection, pafolacianine, 0.1 mg
- A9604Samarium sm-153 lexidronam, therapeutic, per treatment dose, up to 150 millicuries
- A9606Radium ra-223 dichloride, therapeutic, per microcurie
- A9607Lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie
- A9608Flotufolastat f 18, diagnostic, 1 millicurie
- A9609Fludeoxyglucose f18 up to 15 millicuries
- A9610Xenon xe-129 hyperpolarized gas, diagnostic, per study dose
- A9611Flurpiridaz f 18, diagnostic, 1 millicurie
- A9612Injection, fluorescein, 1 mg
Common questions about A9697
Is HCPCS A9697 still valid?
- Yes. A9697 is active in the CMS October 2026 HCPCS file.
Does Medicare cover A9697?
- Its coverage code is "C": coverage is left to the Medicare contractor's judgment. Check the local coverage determination for your region.